Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication regarding Meeting of Board of Directors of the Company scheduled to be held ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges about a Board of Directors meeting scheduled for Saturday, February 14, 2026. The Board will consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and nine months ended December 31, 2025, along with the Limited Review Report from statutory auditors. This newspaper notice was published in Business Standard (English) and Saksham (Telugu local) on February 7, 2026, as required under SEBI LODR Regulation 47. The filing is a routine compliance disclosure ahead of the actual results announcement.
No direct impact on stock price as this is only a procedural intimation; investors should watch for the actual Q3 FY26 results on or after February 14, 2026, which may move the stock depending on the numbers reported.